ArticleEndocrine2014
Treatment satisfaction and glycemic control in young Type 1 diabetic patients in transition from pediatric health care: CSII versus MDI.
Article in Endocrine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Pooled it
- Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis.BMC endocrine disorders · 2015Pooled it
- A Systematic Review of Transitional Care for Emerging Adults with Diabetes.Journal of pediatric nursingPooled it
- Glycemic outcomes with smart MDI system in type 1 diabetes: insights from a 12-Month retrospective study.Endocrine · 2026Observational
- Transitioning Adolescents and Young Adults with Type 1 Diabetes Mellitus in Italy: A Scoping Review.Children (Basel, Switzerland) · 2026Review
- Article
- Article
- Does the Insulin Pump Improve Satisfaction and Glycaemic Control in Moroccan Patients with Type 1 Diabetes?The review of diabetic studies : RDS · 2023Article
- Monitoring of continuous subcutaneous insulin infusion treatment in Portugal and its implications for diabetes management.Hormones (Athens, Greece) · 2023Article
- Article
- Alterations in the Levels of Circulating and Endothelial Progenitor Cells Levels in Young Adults with Type 1 Diabetes: A 2-Year Follow-Up from the Observational METRO Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020Article
- Using insulin pump with a remote-control system in young patients with diabetes improves glycemic control and enhances patient satisfaction.Clinical diabetes and endocrinology · 2019Article
- Transition from pediatric to adult care in emerging adults with type 1 diabetes: a blueprint for effective receivership.Clinical diabetes and endocrinology · 2019Article
- Gender-differences in glycemic control and diabetes related factors in young adults with type 1 diabetes: results from the METRO study.Endocrine · 2018Observational
- Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons.Endocrine · 2018Article
- Observational
- Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill".Endocrine · 2017Article
- Sexual function in young women with type 1 diabetes: the METRO study.Journal of endocrinological investigation · 2017Observational
- Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy.SAGE open medicine · 2017Article
- Erectile dysfunction in young men with type 1 diabetes.International journal of impotence research · 2017Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate whether continuous subcutaneous insulin infusion (CSII) may have any advantage over multiple daily injections (MDI) on glycemic control and treatment satisfaction in young patients with Type 1 diabetes in transition to an adult diabetes center. The study population consisted of 125 patients on MDI; 38 out of the 43 patients considered eligible for CSII completed the study and the 82 remaining on MDI served as control group. Glycemic control and treatment satisfaction [diabetes treatment satisfaction questionnaire (DTSQ)] were evaluated in all patients at baseline and after 12 weeks. At baseline, the two groups were well matched for demographic characteristics and glycemic control. DTSQ score was lower in CSII group (21.1 ± 8.8 vs. 25.1 ± 7.1, P = 0.011). After 12 weeks, a similar decrease in HbA1C was observed in both groups [difference -0.3 % (95 % CI-0.6 to 0.1, P = 0.847)]. Mean amplitude glucose excursions,blood glucose standard deviation, and overall hypoglycemia were significantly reduced in CSII group. DTSQ overall score increased in CSII and decreased in MDI (difference between groups = 9.9, 95 % CI 8.0-12.0, P<0.001), while perceived hyperglycemia and hypoglycemia decreased in CSII compared with MDI (difference:-2.5 and -2.0, respectively, P<0.001 for both). Among young Type 1 diabetic patients in transition from Pediatrics,CSII showed a similar efficacy in reducing HbA1c compared with MDI, with less hypoglycemia and glycemic excursions, and was better in improving overall treatment satisfaction and the rate of perceived hyperglycemia and hypoglycemia.
Indexed as
Identifiers
24078410What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.